VBVipul V. Betkekar

Vipul V. Betkekar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Vipul V. Betkekar has a total of 4 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Total Synthesis of Parameritannin A2, a Branched Epicatechin Tetramer with Two Double Linkages

    by Vipul V. Betkekar, Keisuke Suzuki, Ken Ohmori

    The first total synthesis of parameritannin A2 (1), a branched epicatechin (EC) tetramer is reported. The “phloroglucinol trick” was used to circumvent two synthetic issues encountered when assembling four EC units, namely, the steric constraint and the formation of the C4−C6 interflavan linkage. As a substructure of the middle EC unit, phloroglucinol enabled the single‐step assembly of two EC units (top and side) through A‐type linkages. The middle EC unit was constructed by conducting a newly developed three‐carbon flavan annulation via a Pummerer/Friedel–Crafts cascade reaction to furnish a trimeric intermediate bearing a thio‐leaving group at C4 position, which allowed the final installation of the bottom EC unit.


  • Open Access

    Total Synthesis of Parameritannin A2, a Branched Epicatechin Tetramer with Two Double Linkages

    by Vipul V. Betkekar, Keisuke Suzuki, Ken Ohmori

    The first total synthesis of parameritannin A2 (1), a branched epicatechin (EC) tetramer is reported. The “phloroglucinol trick” was used to circumvent two synthetic issues encountered when assembling four EC units, namely, the steric constraint and the formation of the C4−C6 interflavan linkage. As a substructure of the middle EC unit, phloroglucinol enabled the single‐step assembly of two EC units (top and side) through A‐type linkages. The middle EC unit was constructed by conducting a newly developed three‐carbon flavan annulation via a Pummerer/Friedel–Crafts cascade reaction to furnish a trimeric intermediate bearing a thio‐leaving group at C4 position, which allowed the final installation of the bottom EC unit.


  • Open Access

    Evaluation of Amyloid Polypeptide Aggregation Inhibition and Disaggregation Activity of A-Type Procyanidins

    by Taisei Tanaka, Vipul V. Betkekar, Ken Ohmori, Keisuke Suzuki, Hideyuki Shigemori

    The number of people worldwide suffering from Alzheimer’s disease (AD) and type 2 diabetes (T2D) is on the rise. Amyloid polypeptides are thought to be associated with the onset of both diseases. Amyloid-β (Aβ) that aggregates in the brain and human islet amyloid polypeptide (hIAPP) that aggregates in the pancreas are considered cytotoxic and the cause of the development of AD and T2D, respectively. Thus, inhibiting amyloid polypeptide aggregation and disaggregation existing amyloid aggregates are promising approaches in the therapy and prevention against both diseases. Therefore, in this research, we evaluated the Aβ/hIAPP anti-aggregation and disaggregation activities of A-type procyanidins 1–7 and their substructures 8 and 9, by conducting structure–activity relationship studies and identified the active site. The thioflavin-T (Th-T) assay, which quantifies the degree of aggregation of amyloid polypeptides based on fluorescence intensity, and transmission electron microscopy (TEM), employed to directly observe amyloid polypeptides, were used to evaluate the activity. The results showed that catechol-containing compounds 1–6 exhibited Aβ/hIAPP anti-aggregation and disaggregation activities, while compound 7, without catechol, showed no activity. This suggests that the presence of catechol is important for both activities. Daily intake of foods containing A-type procyanidins may be effective in the prevention and treatment of both diseases.